NFKB1 and prostate cancer: Other signaling pathways which promote migration and invasion induced by LL-37 have been reported in other malignant tumors, such as the NF-κB pathway in melanoma cells [15] and the MAPK/ERK pathway in breast cancer and prostate cancer cells [13,17].